Cargando…

Anti-Tumor Effects of BDH1 in Acute Myeloid Leukemia

Dysregulation of ketone metabolism has been reported in various types of cancer. In order to find out its role in acute myeloid leukemia (AML) pathogenesis, we first analyzed the expression levels of 10 key genes involved in ketone metabolism in AML blasts and CD34(+) hematopoietic stem cells (HSCs)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Fei, Zhao, Huanhuan, Lu, Jun, Yun, Weina, Yang, Lingling, Lou, Yude, Su, Dan, Chen, Xin, Zhang, Shixuan, Jin, Hanwei, Li, Xiang, Sun, Jie, Huang, He, Wang, Qishan, Jiang, Xi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213090/ https://www.ncbi.nlm.nih.gov/pubmed/34150668 http://dx.doi.org/10.3389/fonc.2021.694594

Ejemplares similares

Human BDH2, an anti-apoptosis factor, is a novel poor prognostic factor for de novo cytogenetically normal acute myeloid leukemia
por: Yang, Wen-Chi, et al.
Publicado: (2013)

Expression and clinical significance of BDH1 in liver cancer
por: Liu, Zhicheng, et al.
Publicado: (2021)

The Effects of Human BDH2 on the Cell Cycle, Differentiation, and Apoptosis and Associations with Leukemia Transformation in Myelodysplastic Syndrome
por: Yang, Wen-Chi, et al.
Publicado: (2020)

Successful Anti-CLL1 CAR T-Cell Therapy in Secondary Acute Myeloid Leukemia
por: Zhang, Hui, et al.
Publicado: (2020)

BDH2 triggers ROS-induced cell death and autophagy by promoting Nrf2 ubiquitination in gastric cancer
por: Liu, Jia-Zhou, et al.
Publicado: (2020)

BDH1 promotes lung cancer cell proliferation and metastases by PARP1‐mediated autophagy
por: Zhang, Zhimin, et al.
Publicado: (2023)

Runt-Related Transcription Factor 3 Promotes Acute Myeloid Leukemia Progression
por: Zhang, Wenwen, et al.
Publicado: (2021)

Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
por: Giallongo, Cesarina, et al.
Publicado: (2015)

Inflammation and ER Stress Downregulate BDH2 Expression and Dysregulate Intracellular Iron in Macrophages
por: Zughaier, Susu M., et al.
Publicado: (2014)

Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
por: Wei, Yunxiong, et al.
Publicado: (2020)

Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
por: Barbosa, Karina, et al.
Publicado: (2023)

Acute Myeloid Leukemia With CEBPA Mutations: Current Progress and Future Directions
por: Su, Long, et al.
Publicado: (2022)

Murine Models of Acute Myeloid Leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2022)

Bdh1 overexpression ameliorates hepatic injury by activation of Nrf2 in a MAFLD mouse model
por: Xu, Bu-tuo, et al.
Publicado: (2022)

Corrigendum: Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
por: Wei, Yunxiong, et al.
Publicado: (2020)

Bdh2 Deficiency Promotes Endoderm-Biased Early Differentiation of Mouse Embryonic Stem Cells
por: Fu, Yuting, et al.
Publicado: (2021)

Genomics of Acute Myeloid Leukemia: The Next Generation
por: Riva, Laura, et al.
Publicado: (2012)

Management of Chronic Myeloid Leukemia in Advanced Phase
por: Bonifacio, Massimiliano, et al.
Publicado: (2019)

Clinical Implications of Inflammation in Acute Myeloid Leukemia
por: Récher, Christian
Publicado: (2021)

Debating Frontline Therapy in Chronic Myeloid Leukemia
por: Bi, Xia, et al.
Publicado: (2021)

Editorial: Advances in the treatment of chronic myeloid leukemia
por: Eşkazan, Ahmet Emre, et al.
Publicado: (2023)

Editorial: Precision medicine for acute myeloid leukemia
por: Marconi, Giovanni, et al.
Publicado: (2023)

Corrigendum: Murine models of acute myeloid leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2023)

The Molecular Mechanisms of Resistance to IDH Inhibitors in Acute Myeloid Leukemia
por: Zhuang, Xiaomei, et al.
Publicado: (2022)

Increased PD-1(+)Foxp3(+) γδ T cells associate with poor overall survival for patients with acute myeloid leukemia
por: Zheng, Jiamian, et al.
Publicado: (2022)

Preleukemia and Leukemia-Initiating Cell Activity in inv(16) Acute Myeloid Leukemia
por: Pulikkan, John Anto, et al.
Publicado: (2018)

Harnessing the Metabolic Vulnerabilities of Leukemia Stem Cells to Eradicate Acute Myeloid Leukemia
por: Kumar, Bijender
Publicado: (2021)

Case report: A rare case of acute myeloid leukemia with CPSF6–RARG fusion resembling acute promyelocytic leukemia
por: Zhao, Junmei, et al.
Publicado: (2022)

THBS1 Is a Novel Serum Prognostic Factors of Acute Myeloid Leukemia
por: Zhu, Lidan, et al.
Publicado: (2020)

Methylation of SPRED1: A New Target in Acute Myeloid Leukemia
por: Su, Nan, et al.
Publicado: (2022)

Acute Myeloid Leukemia as a Model for Cancer Therapy
por: Ravandi, Farhad
Publicado: (2012)

Molecular Therapeutic Approaches for Pediatric Acute Myeloid Leukemia
por: Tasian, Sarah K., et al.
Publicado: (2014)

Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia
por: Wingelhofer, Bettina, et al.
Publicado: (2019)

Immunotherapy in Acute Myeloid Leukemia: Where We Stand
por: Isidori, Alessandro, et al.
Publicado: (2021)

Vitamin C Deficiency in Patients With Acute Myeloid Leukemia
por: Ottone, Tiziana, et al.
Publicado: (2022)

Research progress on molecular biomarkers of acute myeloid leukemia
por: Yin, Pei-Yuan, et al.
Publicado: (2023)

Venetoclax plus cyclophosphamide and cytarabine as induction regimen for adult acute myeloid leukemia
por: Zhang, Baohang, et al.
Publicado: (2023)

FLT3-TKD in the prognosis of patients with acute myeloid leukemia: A meta-analysis
por: Li, Shuping, et al.
Publicado: (2023)

A novel scoring system for the quantitative prediction of prognosis in acute myeloid leukemia
por: Yu, Yang, et al.
Publicado: (2023)

E2F6 Impairs Glycolysis and Activates BDH1 Expression Prior to Dilated Cardiomyopathy
por: Major, Jennifer L., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b1qqeab6r74n17u9a12s06k6pi